K Holli Selected Research

K Holli Research Topics

14	Breast Neoplasms (Breast Cancer) 02/2008 - 01/2000
6	Neoplasms (Cancer) 05/2004 - 01/2000
2	Neoplasm Metastasis (Metastasis) 02/2008 - 07/2001
2	Ductal Carcinoma 02/2008 - 05/2004
1	follicular Thyroid cancer 01/2012
1	Papillary Thyroid Cancer 01/2012
1	Thyroid Neoplasms (Thyroid Cancer) 01/2012
1	Pneumonia (Pneumonitis) 02/2006
1	Radiation Pneumonitis 02/2006
1	Cataract (Cataracts) 10/2003
1	Macular Degeneration (Age-Related Maculopathy) 10/2003
1	Leukorrhea 10/2000
1	Pulmonary Embolism 10/2000
1	Venous Thrombosis (Deep-Vein Thrombosis) 10/2000
1	Bone Fractures (Bone Fracture) 10/2000
1	Endometrial Neoplasms (Endometrial Cancer) 09/2000

5	Tamoxifen FDA LinkGeneric 10/2003 - 09/2000
5	Toremifene (Fareston)FDA Link 10/2003 - 09/2000
3	Biological ProductsIBA 05/2004 - 01/2000
3	Progesterone Receptors (Progesterone Receptor)IBA 07/2001 - 01/2000
2	Hormones (Hormone)IBA 05/2004 - 01/2001
2	A-factor (Streptomyces)IBA 07/2001 - 02/2001
2	Estrogen ReceptorsIBA 10/2000 - 01/2000
1	RacivirIBA 01/2012
1	Indicators and Reagents (Reagents)IBA 02/2008
1	Bone Morphogenetic Protein 7IBA 02/2008
1	Biological FactorsIBA 05/2004
1	procollagen type I carboxy terminal peptide (PICP)IBA 07/2001
1	DNA (Deoxyribonucleic Acid)IBA 01/2001
1	P 11 (P-11)IBA 10/2000
1	N 556IBA 10/2000
1	LipidsIBA 10/2000
1	triphenylethyleneIBA 09/2000
1	Estrogen Receptor betaIBA 01/2000
1	Messenger RNA (mRNA)IBA 01/2000
1	Estrogen Receptor alphaIBA 01/2000
1	Estrogens (Estrogen)FDA Link 01/2000

7	Therapeutics 05/2004 - 01/2000
2	Radiotherapy 02/2006 - 01/2001
1	Drug Therapy (Chemotherapy) 02/2001
1	Segmental Mastectomy (Lumpectomy) 01/2001
1	Immunotherapy 01/2000